Live from the NIH registry
Studies recruiting near Canton right now
Top 25 of 304 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cleveland Clinic Mercy Hospital — Canton, Ohio (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Cleveland Clinic Wooster Family Health and Surgery Center — Wooster, Ohio (29.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (20.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Hypochondroplasia
N/A
Observational 400 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: BioMarin Pharmaceutical
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Aultman Health Foundation — Canton, Ohio (0.8 mi)
· Sponsor: NRG Oncology
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Yanke Bionics - W Exchange St — Akron, Ohio (20.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Acute Stroke, Ischemic Stroke
Phase 2, Phase 3
Interventional 728 participants sought
Summa Health Clinical Research Center — Akron, Ohio (20.5 mi)
· Sponsor: DiaMedica Therapeutics Inc
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Cleveland Clinic - Mercy Hospital ( Site 0057) — Canton, Ohio (0.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Platinum-resistant Ovarian Cancer, Testicular Cancer
Phase 1
Interventional 156 participants sought
Gabrail Cancer Center — Canton, Ohio (0.8 mi)
· Sponsor: Context Therapeutics Inc.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Aultman Hospital — Canton, Ohio (0.8 mi)
· Sponsor: Duke University
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-008 — Canton, Ohio (0.8 mi)
· Sponsor: Biohaven Therapeutics Ltd.
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Carcinoma, Non-Small Cell Lung
Phase 1, Phase 2
Interventional 158 participants sought
Gabrail Cancer Center Research — Canton, Ohio (0.8 mi)
· Sponsor: Genprex, Inc.
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (20.5 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Colonic Neoplasms, Neoplasms, Colon
Phase 3
Interventional 892 participants sought
GSK Investigational Site — Akron, Ohio (20.5 mi)
· Sponsor: GlaxoSmithKline
CLAiR Pivotal Study
No Condition
N/A
Observational 942 participants sought
Diabetes and Endocrine Associates of Stark County — Canton, Ohio (0.8 mi)
· Sponsor: Toku Eyes Ltd
Two Dose Levels of Privigen in Pediatric CIDP
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Phase 4
Interventional 30 participants sought
Akron Children's Hospital — Akron, Ohio (20.5 mi)
· Sponsor: CSL Behring
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
University Hospitals Sharon Health Center — Wadsworth, Ohio (24.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Diabetes and Endocrinology Associates of Stark County Inc /ID# 256751 — Canton, Ohio (0.8 mi)
· Sponsor: AbbVie
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Aultman Health Foundation — Canton, Ohio (0.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
Diabetes & Endocrinology Associates of Stark County, Inc. — Canton, Ohio (0.8 mi)
· Sponsor: Housey Healthcare ULC
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Aultman Health Foundation — Canton, Ohio (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
Lipidemia, Type 2 Diabetes (T2DM)
Phase 3
Interventional 300 participants sought
Summit Research Group — Munroe Falls, Ohio (23.6 mi)
· Sponsor: NewAmsterdam Pharma
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Aultman Hospital — Canton, Ohio (0.8 mi)
· Sponsor: Pfizer
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Akron, Ohio (20.5 mi)
· Sponsor: Medtronic
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
Aultman Health Foundation — Canton, Ohio (0.8 mi)
· Sponsor: City of Hope Medical Center